Cargando…

Effect of Intensive Blood Pressure Control on Cardiovascular Remodeling in Hypertensive Patients with Nephrosclerosis

Pulse pressure (PP), a marker of arterial system properties, has been linked to cardiovascular (CV) complications. We examined (a) association between unit changes of PP and (i) composite CV outcomes and (ii) development of left-ventricular hypertrophy (LVH) and (b) effect of mean arterial pressure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Randall, Otelio, Kwagyan, John, Retta, Tamrat, Jamerson, Kenneth, Pogue, Velvie, Norris, Keith, Ketete, Muluemebet, Xu, Shichen, Greene, Tom, Wang, Xuelei, Agodoa, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786477/ https://www.ncbi.nlm.nih.gov/pubmed/24102027 http://dx.doi.org/10.1155/2013/120167

Ejemplares similares

Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans
por: Duraimani, Shanthi, et al.
Publicado: (2015)

Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race
por: Hughson, Michael D., et al.
Publicado: (2014)

Investigation into the underlying molecular mechanisms of hypertensive nephrosclerosis using bioinformatics analyses
por: Liu, Tianlong, et al.
Publicado: (2018)

Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis
por: Bramlage, Carsten P, et al.
Publicado: (2010)

Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy
por: Gutsol, Alex A., et al.
Publicado: (2022)

Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis
por: Momoki, Kumiko, et al.
Publicado: (2017)

Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2019)

Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis
por: Bhalla, Meeta, et al.
Publicado: (2012)

Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
por: Fanelli, Camilla, et al.
Publicado: (2023)

Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study
por: Liang, Shaoshan, et al.
Publicado: (2016)

Comparison of 6 equations for estimating glomerular filtration rate in a Chinese benign hypertensive nephrosclerosis population
por: Ke, Guibao, et al.
Publicado: (2021)

Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions
por: Nakayama, Yuki, et al.
Publicado: (2022)

Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
por: González, Luz M., et al.
Publicado: (2023)

Kidney Disease in Disadvantaged Populations
por: Martins, David, et al.
Publicado: (2012)

The Renal Protective Effect of Jiangya Tongluo Formula, through Regulation of Adrenomedullin and Angiotensin II, in Rats with Hypertensive Nephrosclerosis
por: Han, Lin, et al.
Publicado: (2015)

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis
por: Øvrehus, Marius A., et al.
Publicado: (2018)

Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
por: González, Luz María, et al.
Publicado: (2021)

Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
por: Nordbø, Ole Petter, et al.
Publicado: (2023)

Foreword - Kidney disease in disadvantaged populations: an unconquered challenge
por: Prabhakar, Kowdle S., et al.
Publicado: (2015)

Foreword - Kidney disease in disadvantaged populations: An unconquered challenge
por: Norris, Keith C., et al.
Publicado: (2016)

Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis
por: Sumida, Keiichi, et al.
Publicado: (2016)

Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
por: González, Luz M., et al.
Publicado: (2022)

A Case of Significant Improvement of Heart Failure With Reduced Ejection Fraction With a Small Dose of Candesartan in a Hemodialysis Patient With Hypertensive Heart Disease and Nephrosclerosis
por: Harada, Haruhito, et al.
Publicado: (2023)

Prostacyclin analog beraprost sodium efficacy in primary glomerular disease or nephrosclerosis: Analysis of the Japanese subgroup in CASSIOPEIR study
por: Kurumatani, Hajimu, et al.
Publicado: (2021)

Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation
por: Wang, Zheng, et al.
Publicado: (2023)

Use of Percutaneous Coronary Intervention Among Black and White Patients With End‐Stage Renal Disease in the United States
por: Nee, Robert, et al.
Publicado: (2019)

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map
por: Abe, Masanori, et al.
Publicado: (2016)

Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR)
por: Sumida, Keiichi, et al.
Publicado: (2021)

Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival
por: Abbott, Kevin C, et al.
Publicado: (2002)

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study design
por: Nakamoto, Hidetomo, et al.
Publicado: (2014)

Pathophysiology of Vascular Remodeling in Hypertension
por: Renna, Nicolás F., et al.
Publicado: (2013)

Vascular Remodeling in Experimental Hypertension
por: Risler, Norma R., et al.
Publicado: (2005)

Mood Responses to Passive and Active Motion Leg Cycling Exercise in Healthy Sedentary Young Adults
por: Bond Jr., Vernon, et al.
Publicado: (2020)

Hospitalized poisonings after renal transplantation in the United States
por: Abbott, Kevin C, et al.
Publicado: (2002)

Pulmonary Vascular Remodeling in Pulmonary Hypertension
por: Jia, Zhuangzhuang, et al.
Publicado: (2023)

High Intensity Interval and Endurance Training Have Opposing Effects on Markers of Heart Failure and Cardiac Remodeling in Hypertensive Rats
por: Holloway, Tanya M., et al.
Publicado: (2015)

3128 Copula-Based Regression Models for Correlated Bivariate Binary Outcomes: Application to Ophthalmologic Data Structures
por: Alqahtani, Haifa, et al.
Publicado: (2019)

Worse Blood Pressure Levels and Control During Nonsummer Months in Rigorously Treated Patients With Hypertension: The ACCOMPLISH Trial
por: Brook, Robert D., et al.
Publicado: (2023)

Low‐intensity aerobic exercise improves cardiac remodelling of adult spontaneously hypertensive rats
por: Pagan, Luana U., et al.
Publicado: (2019)

Effects of Hypertension and Exercise on Cardiac Proteome Remodelling
por: Petriz, Bernardo A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vjtagto07nqme8aga48mr4n6un